SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-206613
Filing Date
2014-05-20
Accepted
2014-05-20 16:34:41
Documents
10
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d723855d10q.htm 10-Q 306978
2 EX-31.1 d723855dex311.htm EX-31.1 8057
3 EX-31.2 d723855dex312.htm EX-31.2 8034
4 EX-32.1 d723855dex321.htm EX-32.1 3037
  Complete submission text file 0001193125-14-206613.txt   2812132

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT xbio-20140331.xml EX-101.INS 276711
6 XBRL TAXONOMY EXTENSION SCHEMA xbio-20140331.xsd EX-101.SCH 37987
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xbio-20140331_cal.xml EX-101.CAL 54776
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xbio-20140331_def.xml EX-101.DEF 97303
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE xbio-20140331_lab.xml EX-101.LAB 270409
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xbio-20140331_pre.xml EX-101.PRE 189969
Mailing Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421 781-778-7722
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-178082 | Film No.: 14858342
SIC: 2834 Pharmaceutical Preparations